Search - tctmd.com

Displaying 561 - 580 of 714

Sort: Relevancy | Date

News Daily News

采用Sapien 3经股动脉植入时，死亡率和卒中发生率均很低

December 04, 2014

News Daily News

Sapien 3 Ups Need for Pacemaker Compared With Its Predecessor, But Reduces Moderate-Severe Paravalvular Leak

Todd Neale

December 04, 2014

News Daily News

Sapien 3 TAVR器械与较早的器械相比会增加对起搏器的需求

Todd Neale

December 04, 2014

News Daily News

Low Mortality, Stroke With Transfemoral Implant of Sapien 3

December 04, 2014

News Daily News

El Dispositivo TAVR Sapien 3 Supera la Necesidad de Marcapasos comparado con su Predecesor

Todd Neale

December 04, 2014

News Daily News

Bajo Índice de Mortalidad y ACV con el Implante Transfemoral de Sapien 3

December 04, 2014

News Industry News

Medtronic Studies Show Cardiac Resynchronization Therapy Extends Life, Reduces Hospital Readmissions

November 15, 2014

News Daily News

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

October 17, 2014

News Industry News

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

October 13, 2014

News Industry News

St. Jude Medical Nanostim Leadless Pacemaker Receives Prestigious Award at the Annual Phoenix Conference

September 15, 2014

News Conference News TCT 2014

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

September 14, 2014

News Conference News TCT 2014

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

September 13, 2014

News Conference News ESC 2014

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Caitlin E. Cox

September 02, 2014

News Conference News ESC 2014

Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis

Caitlin E. Cox

August 31, 2014

News Industry News

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

August 25, 2014

News Daily News

GARY: Majority of Patients Do Well With TAVR or Surgery at 1 Year

L.A. McKeown

August 20, 2014

News Industry News

Minneapolis Heart Institute Foundation Announces Its First Implant of Portico Aortic Heart Valve System

August 18, 2014

News Industry News

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in(1)

July 22, 2014

News Industry News

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in EuroIntervention

July 22, 2014

Advertisement

采用Sapien 3经股动脉植入时，死亡率和卒中发生率均很低

Sapien 3 Ups Need for Pacemaker Compared With Its Predecessor, But Reduces Moderate-Severe Paravalvular Leak

Sapien 3 TAVR器械与较早的器械相比会增加对起搏器的需求

Low Mortality, Stroke With Transfemoral Implant of Sapien 3

El Dispositivo TAVR Sapien 3 Supera la Necesidad de Marcapasos comparado con su Predecesor

Bajo Índice de Mortalidad y ACV con el Implante Transfemoral de Sapien 3

Medtronic Studies Show Cardiac Resynchronization Therapy Extends Life, Reduces Hospital Readmissions

Preexisting—But Not New-Onset—A-fib Predicts Worse Long-term Outcomes After TAVR

Medtronic CoreValve System Shows Exceptional Outcomes and Valve Performance in TAVI Patients Treated Via Direct Aortic Access

St. Jude Medical Nanostim Leadless Pacemaker Receives Prestigious Award at the Annual Phoenix Conference

Registry Data Show Promise of Valve-in-Valve TAVR in High-Risk Patients

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

GARY: Transapical TAVR Appears Inherently Riskier Than Transvascular

Single-Center Study Compares TAVR Devices in Mixed Aortic Stenosis

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

GARY: Majority of Patients Do Well With TAVR or Surgery at 1 Year

Minneapolis Heart Institute Foundation Announces Its First Implant of Portico Aortic Heart Valve System

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in(1)

Results of first-in-human study of Transcatheter Technologies’ TAVI device, TRINITY, are reported in EuroIntervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content